154 related articles for article (PubMed ID: 29632530)
1. Ezh2 Regulates Activation-Induced CD8
Chen G; Subedi K; Chakraborty S; Sharov A; Lu J; Kim J; Mi X; Wersto R; Sung MH; Weng NP
Front Immunol; 2018; 9():549. PubMed ID: 29632530
[TBL] [Abstract][Full Text] [Related]
2. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus.
Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S
Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298
[TBL] [Abstract][Full Text] [Related]
3. The polycomb repressive complex 2 governs life and death of peripheral T cells.
Zhang Y; Kinkel S; Maksimovic J; Bandala-Sanchez E; Tanzer MC; Naselli G; Zhang JG; Zhan Y; Lew AM; Silke J; Oshlack A; Blewitt ME; Harrison LC
Blood; 2014 Jul; 124(5):737-49. PubMed ID: 24951427
[TBL] [Abstract][Full Text] [Related]
4. EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index.
Purkait S; Sharma V; Jha P; Sharma MC; Suri V; Suri A; Sharma BS; Sarkar C
Neuropathology; 2015 Oct; 35(5):421-31. PubMed ID: 26096306
[TBL] [Abstract][Full Text] [Related]
5. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells.
Yang X; Karuturi RK; Sun F; Aau M; Yu K; Shao R; Miller LD; Tan PB; Yu Q
PLoS One; 2009; 4(4):e5011. PubMed ID: 19340297
[TBL] [Abstract][Full Text] [Related]
6. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.
Aoki R; Chiba T; Miyagi S; Negishi M; Konuma T; Taniguchi H; Ogawa M; Yokosuka O; Iwama A
J Hepatol; 2010 Jun; 52(6):854-63. PubMed ID: 20395008
[TBL] [Abstract][Full Text] [Related]
7. Ezh2 programs T
Li F; Zeng Z; Xing S; Gullicksrud JA; Shan Q; Choi J; Badovinac VP; Crotty S; Peng W; Xue HH
Nat Commun; 2018 Dec; 9(1):5452. PubMed ID: 30575739
[TBL] [Abstract][Full Text] [Related]
8. Roles of histone H3K27 trimethylase Ezh2 in retinal proliferation and differentiation.
Iida A; Iwagawa T; Baba Y; Satoh S; Mochizuki Y; Nakauchi H; Furukawa T; Koseki H; Murakami A; Watanabe S
Dev Neurobiol; 2015 Sep; 75(9):947-60. PubMed ID: 25556712
[TBL] [Abstract][Full Text] [Related]
9. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
10. Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8
Gray SM; Amezquita RA; Guan T; Kleinstein SH; Kaech SM
Immunity; 2017 Apr; 46(4):596-608. PubMed ID: 28410989
[TBL] [Abstract][Full Text] [Related]
11. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
[TBL] [Abstract][Full Text] [Related]
12. Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value.
Meseure D; Vacher S; Alsibai KD; Nicolas A; Chemlali W; Caly M; Lidereau R; Pasmant E; Callens C; Bieche I
Mol Cancer Res; 2016 Jul; 14(7):623-33. PubMed ID: 27102007
[TBL] [Abstract][Full Text] [Related]
13. FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis.
Zhang Y; Tong T
Biochem Biophys Res Commun; 2014 Oct; 453(1):172-8. PubMed ID: 25264199
[TBL] [Abstract][Full Text] [Related]
14. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription.
Li Q; Li B; Dong C; Wang Y; Li Q
Eur J Pharmacol; 2017 Nov; 815():173-180. PubMed ID: 28928088
[TBL] [Abstract][Full Text] [Related]
15. Disruption of FOXP3-EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation.
Bamidele AO; Svingen PA; Sagstetter MR; Sarmento OF; Gonzalez M; Braga Neto MB; Kugathasan S; Lomberk G; Urrutia RA; Faubion WA
Cell Mol Gastroenterol Hepatol; 2019; 7(1):55-71. PubMed ID: 30510991
[TBL] [Abstract][Full Text] [Related]
16. Lysine methyltransferase Kmt2d regulates naive CD8
Kim J; Nguyen T; Cifello J; Ahmad R; Zhang Y; Yang Q; Lee JE; Li X; Kai Y; De S; Peng W; Ge K; Weng NP
Front Immunol; 2022; 13():1095140. PubMed ID: 36741385
[TBL] [Abstract][Full Text] [Related]
17. EZH2 as a Regulator of CD8+ T Cell Fate and Function.
Stairiker CJ; Thomas GD; Salek-Ardakani S
Front Immunol; 2020; 11():593203. PubMed ID: 33117406
[TBL] [Abstract][Full Text] [Related]
18. Ezh2 maintains retinal progenitor proliferation, transcriptional integrity, and the timing of late differentiation.
Zhang J; Taylor RJ; La Torre A; Wilken MS; Cox KE; Reh TA; Vetter ML
Dev Biol; 2015 Jul; 403(2):128-38. PubMed ID: 25989023
[TBL] [Abstract][Full Text] [Related]
19. Dual Role of EZH2 in Cutaneous Anaplastic Large Cell Lymphoma: Promoting Tumor Cell Survival and Regulating Tumor Microenvironment.
Yi S; Sun J; Qiu L; Fu W; Wang A; Liu X; Yang Y; Kadin ME; Tu P; Wang Y
J Invest Dermatol; 2018 May; 138(5):1126-1136. PubMed ID: 29248547
[TBL] [Abstract][Full Text] [Related]
20. G0S2 modulates homeostatic proliferation of naïve CD8⁺ T cells and inhibits oxidative phosphorylation in mitochondria.
Lee PH; Yamada T; Park CS; Shen Y; Puppi M; Lacorazza HD
Immunol Cell Biol; 2015 Aug; 93(7):605-15. PubMed ID: 25666096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]